158.4K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 71,254 | 71,254 | - | - | Stock Option (right to buy) | |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. | 02 Jan 2025 | 10,827 | 267,434 | - | 1.8 | 19,380 | Class A Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. | 02 Jan 2025 | 1,205 | 158,349 | - | 1.8 | 2,157 | Class A Common Stock |
| Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. | 02 Jan 2025 | 6,120 | 151,694 | - | 1.8 | 10,955 | Class A Common Stock |
| Lisa Locklear | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. | 02 Jan 2025 | 6,120 | 152,195 | - | 1.8 | 10,955 | Class A Common Stock |
| Khoso Baluch | Director | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 02 Dec 2024 | 1,250 | 23,750 | - | 2.1 | 2,588 | Class A Common Stock |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 01 Oct 2024 | 13,357 | 278,261 | - | 1.9 | 25,111 | Class A Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 01 Oct 2024 | 990 | 159,554 | - | 1.9 | 1,861 | Class A Common Stock |
| Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 01 Oct 2024 | 5,316 | 157,814 | - | 1.9 | 9,994 | Class A Common Stock |
| Lisa Locklear | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 01 Oct 2024 | 5,316 | 158,315 | - | 1.9 | 9,994 | Class A Common Stock |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 311,250 | 330,866 | - | 0 | Class A Common Stock | |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 28,750 | 28,750 | - | - | Stock Option (right to buy) | |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 15 Aug 2024 | 39,248 | 90,368 | - | 2.5 | 96,550 | Class A Common Stock |
| Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 38,375 | - | 0 | Class A Common Stock | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 93,766 | 727,046 | - | 0 | Class A Common Stock | |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 178,133 | 320,214 | - | 0 | Class A Common Stock | |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 15 Aug 2024 | 31,505 | 288,709 | - | 2.5 | 77,502 | Class A Common Stock |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Neil E. Hare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 29,352 | - | 0 | Class A Common Stock | |
| Rock Soffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 232,034 | - | 0 | Class A Common Stock | |
| Ursula Ungaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 24,000 | - | 0 | Class A Common Stock | |
| Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 15 Aug 2024 | 14,391 | 163,130 | - | 2.5 | 35,402 | Class A Common Stock |
| Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 175,750 | 177,521 | - | 0 | Class A Common Stock | |
| Lisa Locklear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 16,250 | 16,250 | - | - | Stock Option (Right to Buy) | |
| Lisa Locklear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 174,750 | 177,666 | - | 0 | Class A Common Stock | |
| Lisa Locklear | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 15 Aug 2024 | 14,035 | 163,631 | - | 2.5 | 34,526 | Class A Common Stock |
| Roger Hajjar | Director | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 02 Jul 2024 | 16,000 | 16,000 | - | 1.7 | 26,880 | Class A Common Stock |
| Neha Motwani | Director | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 02 Jul 2024 | 16,000 | 16,000 | - | 1.7 | 26,880 | Class A Common Stock |
| Lisa Locklear | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 01 Jul 2024 | 357 | 2,916 | - | 1.6 | 560 | Class A Common Stock |
| Khoso Baluch | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 09 Jun 2024 | 125 | 14,875 | - | 1.1 | 133 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.04 per share. | 03 Jun 2024 | 325 | 142,081 | - | 1.0 | 338 | Class A Common Stock |
| Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 1.46 per share. | 10 May 2024 | 16,000 | 16,000 | - | 1.5 | 23,280 | Class A Common Stock |
| Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.83 per share. | 02 May 2024 | 308 | 1,771 | - | 2.8 | 872 | Class A Common Stock |
| Lisa Locklear | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.83 per share. | 02 May 2024 | 410 | 3,273 | - | 2.8 | 1,160 | Class A Common Stock |
| Mohamed Wael Ahmed Hashad | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 11 Apr 2024 | 10,638 | 19,616 | - | 2.3 | 24,999 | Class A Common Stock |
| Mohamed Wael Ahmed Hashad | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Apr 2024 | 10,638 | 10,638 | - | - | Warrant (right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Apr 2024 | 42,553 | 42,553 | - | - | Warrant (right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Apr 2024 | 106,383 | 106,383 | - | - | Warrant (right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 10 Apr 2024 | 42,553 | 633,280 | - | 2.4 | 100,000 | Class A Common Stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 10 Apr 2024 | 106,383 | 590,727 | - | 2.3 | 250,000 | Class A Common Stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Apr 2024 | 31,915 | 31,915 | - | - | Warrant (right to buy) | |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 10 Apr 2024 | 106,383 | 176,619 | - | 2.3 | 250,000 | Class A Common Stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 10 Apr 2024 | 31,915 | 208,534 | - | 2.3 | 75,000 | Class A Common Stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Apr 2024 | 106,383 | 106,383 | - | - | Warrant (right to buy) | |
| Mohamed Wael Ahmed Hashad | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 12 Mar 2024 | 32,866 | 89,777 | - | 0.5 | 17,748 | Common Stock, par value $0.001 per share |
| Mohamed Wael Ahmed Hashad | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 80,200 | 122,643 | - | 0 | Common Stock, par value $0.001 per share | |
| Cathy Ross | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 10 Jan 2024 | 5,000 | 10,000 | - | 1.3 | 6,545 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Jan 2024 | 992 | 142,406 | - | 1.3 | 1,309 | Common Stock |
| Hashad Mohamed Wael Ahmed | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Jan 2024 | 5,123 | 42,443 | - | 1.3 | 6,762 | Common Stock |
| Locklear Lisa | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Jan 2024 | 4,098 | 36,824 | - | 1.3 | 5,409 | Common Stock |
| Agafonova Nataliya | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Jan 2024 | 3,074 | 20,786 | - | 1.3 | 4,058 | Common Stock |
| Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 28 Dec 2023 | 8,322 | 15,000 | - | 1.4 | 11,915 | Common Stock |
| Jeffrey Pfeffer | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 28 Dec 2023 | 10,000 | 15,000 | - | 1.4 | 13,500 | Common Stock |
| Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 28 Dec 2023 | 1,678 | 6,678 | - | 1.4 | 2,342 | Common Stock |
| Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Hare Joshua M. | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| W. Losordo Douglas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Ungaro Ursula | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Neil E. Hare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Jeffrey Pfeffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Soffer Rock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Cathy Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 18 Aug 2023 | 4,292 | 41,889 | - | 3.3 | 13,949 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 18 Aug 2023 | 767 | 142,213 | - | 3.3 | 2,493 | Common Stock |
| Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.36 per share. | 18 Aug 2023 | 3,081 | 26,919 | - | 3.4 | 10,352 | Common Stock |
| Lisa Locklear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 40,000 | 40,000 | - | 0 | Common Stock | |
| Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| James Clavijo | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 27 Jun 2023 | 10,000 | 52,303 | - | 3.4 | 34,300 | Common Stock |
| James Clavijo | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 3.51 per share. | 27 Jun 2023 | 5,000 | 47,303 | - | 3.5 | 17,550 | Common Stock |
| James Clavijo | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 27 Jun 2023 | 8,532 | 62,303 | - | 3.5 | 29,691 | Common Stock |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. | 09 Jun 2023 | 752 | 70,835 | - | 3.4 | 2,572 | Common Stock |
| Jeffrey Pfeffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 02 Jun 2023 | 3,247 | 71,587 | - | 3.3 | 10,553 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 02 Jun 2023 | 3,247 | 142,980 | - | 3.3 | 10,553 | Common Stock |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.61 per share. | 05 Apr 2023 | 3,819 | 46,181 | - | 2.6 | 9,968 | Common Stock |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.61 per share. | 03 Apr 2023 | 815 | 74,834 | - | 2.6 | 2,127 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.61 per share. | 03 Apr 2023 | 815 | 146,227 | - | 2.6 | 2,127 | Common Stock |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Ahmed Hashad Mohamed Wael | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.28 per share. | 27 Jan 2023 | 20,000 | 7,793,263 | - | 4.3 | 85,600 | Common Stock |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 03 Jan 2023 | 1,288 | 75,649 | - | 3.4 | 4,341 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 03 Jan 2023 | 1,472 | 147,042 | - | 3.4 | 4,961 | Common Stock |
| James Clavijo | CFO and Treasurer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 5,000 | 70,649 | - | 0 | Common Stock | |
| Douglas W. Losordo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Todd C. Girolamo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Donald M. Soffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Neil E. Hare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Rock Soffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Erin Borger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Cathy Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Ursula Ungaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 02 Dec 2022 | 20,000 | 7,813,263 | - | 3.7 | 74,800 | Common Stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.61 per share. | 12 Oct 2022 | 100,000 | 7,813,263 | - | 3.6 | 361,000 | Common Stock |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share. | 03 Oct 2022 | 1,256 | 76,937 | - | 3.8 | 4,710 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share. | 03 Oct 2022 | 1,435 | 148,514 | - | 3.7 | 5,381 | Common Stock |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.94 per share. | 01 Jul 2022 | 1,426 | 78,193 | - | 5.9 | 8,470 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.94 per share. | 01 Jul 2022 | 1,629 | 149,949 | - | 5.9 | 9,676 | Common Stock |
| James Clavijo | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 40,000 | 116,574 | - | 0 | Common stock | |
| James Clavijo | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 8.26 per share. | 03 Jun 2022 | 36,955 | 79,619 | - | 8.3 | 305,248 | Common stock |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 40,000 | 151,578 | - | 0 | Common stock | |
| Rock Soffer | Director | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 20 May 2022 | 4,000 | 672,351 | - | 7.5 | 30,000 | Common stock |
| Rock Soffer | Director | Sale of securities on an exchange or to another person at price $ 8.06 per share. | 20 May 2022 | 7,500 | 684,351 | - | 8.1 | 60,435 | Common stock |
| Rock Soffer | Director | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 20 May 2022 | 8,000 | 676,351 | - | 7.8 | 62,200 | Common stock |
| Donald M. Soffer | Director | Other type of transaction at price $ 0.00 per share. | 17 May 2022 | 7,024,208 | 0 | - | 0 | Common Stock | |
| Donald M. Soffer | Director | Other type of transaction at price $ 0.00 per share. | 17 May 2022 | 6,535,223 | 6,693,737 | - | 0 | Common Stock | |
| Rock Soffer | Director | Other type of transaction at price $ 0.00 per share. | 17 May 2022 | 500,182 | 691,851 | - | 0 | Common Stock | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 18 Apr 2022 | 19,922 | 7,913,341 | - | 10.0 | 199,290 | Common stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 18 Apr 2022 | 78 | 7,913,263 | - | 10 | 780 | Common stock |
| Donald M. Soffer | Director | Other type of transaction at price $ 0.00 per share. | 13 Apr 2022 | 748,694 | 7,024,208 | - | 0 | Common Stock | |
| Rock Soffer | Director | Other type of transaction at price $ 0.00 per share. | 13 Apr 2022 | 139,912 | 191,669 | - | 0 | Common Stock | |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.61 per share. | 04 Apr 2022 | 1,288 | 76,574 | - | 15.6 | 20,106 | Common stock |
| Geoff Green | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.61 per share. | 04 Apr 2022 | 1,840 | 133,904 | - | 15.6 | 28,722 | Common stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.61 per share. | 04 Apr 2022 | 1,472 | 111,578 | - | 15.6 | 22,978 | Common stock |
| Kwan-Hong Christopher Min | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 150,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Kwan-Hong Christopher Min | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 2,335 | 2,335 | - | - | Stock Option (right to buy) | |
| Kwan-Hong Christopher Min | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 150,000 | 151,978 | - | 0 | Common Stock | |
| Kwan-Hong Christopher Min | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2022 | 357 | 1,978 | - | 0 | Common Stock | |
| Kwan-Hong Christopher Min | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 2,335 | 2,335 | - | 0 | Common Stock | |
| James Clavijo | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. | 03 Jan 2022 | 1,736 | 77,862 | - | 12.1 | 20,988 | Common Stock |
| Geoff Green | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. | 03 Jan 2022 | 3,979 | 135,744 | - | 12.1 | 48,106 | Common Stock |
| Paul Lehr | General Counsel, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. | 03 Jan 2022 | 3,316 | 113,050 | - | 12.1 | 40,090 | Common Stock |
| Geoff Green | CEO | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 13 Oct 2021 | 1,000 | 139,723 | - | 3.8 | 3,810 | Common stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 12 Oct 2021 | 2,500 | 7,933,263 | - | 3.7 | 9,225 | Common stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 11 Oct 2021 | 3,900 | 35,757 | - | 3.5 | 13,455 | Common stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 3.76 per share. | 11 Oct 2021 | 12,000 | 51,757 | - | 3.8 | 45,120 | Common stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 3.57 per share. | 11 Oct 2021 | 4,000 | 39,757 | - | 3.6 | 14,280 | Common stock |
| James Clavijo | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 07 Oct 2021 | 5,000 | 79,598 | - | 3.3 | 16,700 | Common stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 07 Oct 2021 | 3,015 | 7,930,763 | - | 3.4 | 10,221 | Common stock |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 07 Oct 2021 | 1,985 | 7,927,748 | - | 3.4 | 6,709 | Common stock |
| Paul Lehr | General Counsel, Secretary | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 07 Oct 2021 | 1,750 | 116,366 | - | 3.3 | 5,845 | Common stock |
| James Clavijo | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Geoff Green | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 8,223 | 182,652 | - | 0 | Common Stock | |
| Geoff Green | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 12,335 | 7,925,763 | - | 0 | Common Stock | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Paul Lehr | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 6,167 | 153,368 | - | 0 | Common Stock | |
| Ursula Ungaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 5,000 | 5,000 | - | 0 | Common stock | |
| Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 7,913,428 | - | 0 | Common Stock | |
| Donald M. Soffer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 158,514 | - | 0 | Common Stock | |
| Neil E. Hare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 58,514 | - | 0 | Common Stock | |
| Rock Soffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 31,857 | - | 0 | Common Stock | |
| Erin Borger | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2021 | 5,000 | 0 | - | 0 | Common Stock | |
| Douglas W. Losordo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 5,000 | 5,000 | - | 0 | Common stock | |
| Joshua M. Hare | Director, Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 12 Feb 2021 | 12,000 | 7,908,428 | - | 10 | 120,000 | Common Stock |
| Donald M. Soffer | Director | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 12 Feb 2021 | 100,000 | 153,514 | - | 10 | 1,000,000 | Common Stock |
| Rock Soffer | Director | Purchase of securities on an exchange or from another person at price $ 8.05 per share. | 12 Feb 2021 | 100 | 26,857 | - | 8.1 | 805 | Common Stock |
| Erin Borger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Cathy Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 5,000 | 5,000 | - | 0 | Common Stock |